• Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics

    Monday June 14th 2021

  • RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV

    Wednesday June 2nd 2021

  • Investment in Flow Cytometry unlocks the secrets of single cells

    Thursday May 20th 2021

  • Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski

    Tuesday May 11th 2021

  • Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance

    Tuesday May 11th 2021

  • Biocartis announces US FDA 510(k) submission of its Idylla™ MSI Test

    Tuesday April 20th 2021

  • The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million

    Wednesday April 14th 2021

  • Confo Therapeutics awarded EUR 1M VLAIO grant for pre-clinical development of CFTX-1554

    Wednesday March 31st 2021

  • Your news here?

  • Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases

    Tuesday March 23rd 2021

  • AgomAb Therapeutics kondigt $74 miljoen series-B financiering aan

    Wednesday March 10th 2021

  • Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products

    Tuesday March 2nd 2021

Strategic Partners